MARKET

ELOX

ELOX

Eloxx Pharmaceut
NASDAQ
20.98
+2.94
+16.27%
After Hours: 20.98 0 0.00% 19:30 08/21 EDT
OPEN
19.00
PREV CLOSE
18.04
HIGH
23.40
LOW
18.04
VOLUME
93.39K
TURNOVER
--
52 WEEK HIGH
23.40
52 WEEK LOW
0.0011
MARKET CAP
84.66M
P/E (TTM)
-13.8030
1D
5D
1M
3M
1Y
5Y
1D
Eloxx Q2 Loss Widens; Exaluren Phase 2b Trial Set To Begin In Q3 2026
NASDAQ · 1d ago
Eloxx Pharmaceuticals Price Target Announced at $38.00/Share by LUCID CAPITAL MARKETS
Dow Jones · 2d ago
LUCID CAPITAL MARKETS Initiates Coverage On Eloxx Pharma with Buy Rating, Announces Price Target of $38
Benzinga · 2d ago
Eloxx Pharmaceuticals initiated with a Buy at Lucid Capital
TipRanks · 2d ago
Weekly Report: what happened at ELOX last week (0810-0814)?
Weekly Report · 5d ago
Eloxx Maintained at Buy as Strong Exaluren Pipeline and Solid Cash Runway Support Unchanged $40 Price Target
TipRanks · 08/12 10:35
Eloxx Pharmaceuticals, Inc. Loss At -$4.50 Mln In Q2
NASDAQ · 08/12 10:29
*Eloxx Pharmaceuticals 2Q Loss/Shr 66c >ELOX
Dow Jones · 08/12 10:00
More
About ELOX
Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the science of ribosome modulation, leveraging both its TURBO- ZM chemistry technology platform and its library of aminoglycosides to develop oral small-molecule ribosome modulating agents (RMAs) and eukaryotic ribosome selective glycosides (ERSGs) for the treatment of rare and ultra-rare genetic diseases. Its lead investigational product candidate, ELX-02, is a small molecule drug candidate designed to restore production of full-length functional proteins. The Company is also advancing ZKN-013 as an oral agent for the treatment of recessive dystrophic (RDEB)/ junctional epidermolysis bullosa (JEB) and familial adenomatous polyposis (FAP) patients with nonsense mutations. The Company also has preclinical programs focused on select rare diseases, including inherited diseases, cancer caused by nonsense mutations, kidney diseases, as well as rare ocular genetic disorders.

Webull offers Eloxx Pharmaceuticals Inc stock information, including NASDAQ: ELOX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ELOX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ELOX stock methods without spending real money on the virtual paper trading platform.